Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

Cited In for PubMed (Select 19707431)

1.

SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.

Chen YW, Hsiao PJ, Weng CC, Kuo KK, Kuo TL, Wu DC, Hung WC, Cheng KH.

BMC Cancer. 2014 Mar 14;14:181. doi: 10.1186/1471-2407-14-181.

2.

Molecular imaging of nonsmall cell lung carcinomas expressing active mutant EGFR kinase using PET with [(124)i]-morpholino-IPQA.

Yeh SH, Lin CF, Kong FL, Wang HE, Hsieh YJ, Gelovani JG, Liu RS.

Biomed Res Int. 2013;2013:549359. doi: 10.1155/2013/549359. Epub 2013 Jul 17.

3.

Ritonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer.

Pillai VC, Venkataramanan R, Parise RA, Christner SM, Gramignoli R, Strom SC, Rudek MA, Beumer JH.

Drug Metab Dispos. 2013 Oct;41(10):1843-51. doi: 10.1124/dmd.113.052100. Epub 2013 Aug 2.

4.
5.

Efficacy of minimally invasive therapies on unresectable pancreatic cancer.

Huang ZM, Pan CC, Wu PH, Zhao M, Li W, Huang ZL, Yi RY.

Chin J Cancer. 2013 Jun;32(6):334-41. doi: 10.5732/cjc.012.10093. Epub 2012 Sep 10.

6.

Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings.

Hodges K, Kennedy L, Meng F, Alpini G, Francis H.

Transl Gastrointest Cancer. 2012 Jul 1;1(2):138-150. Epub 2012 Feb 8.

7.

Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly.

Neveu G, Barouch-Bentov R, Ziv-Av A, Gerber D, Jacob Y, Einav S.

PLoS Pathog. 2012;8(8):e1002845. doi: 10.1371/journal.ppat.1002845. Epub 2012 Aug 16.

8.

Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells.

Ioannou N, Dalgleish AG, Seddon AM, Mackintosh D, Guertler U, Solca F, Modjtahedi H.

Br J Cancer. 2011 Nov 8;105(10):1554-62. doi: 10.1038/bjc.2011.396. Epub 2011 Oct 4.

9.

EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

Kanwar SS, Nautiyal J, Majumdar AP.

Curr Drug Targets. 2010 Jun;11(6):682-98. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk